Gas6/Axl signaling has emerged as a driver of hepatocellular carcinoma (HCC) progression, impacting several cellular processes, including the epithelial-to-mesenchymal transition (EMT) and metastasis [1]. This evidence concerns the gene GAS6 and hepatocellular carcinoma.